Citigroup Cut RTX (NYSE:RTX) Price Target to $95.00 From $113.50
Citigroup Maintained RTX (NYSE:RTX) with a Neutral rating and Cut the Price Target to $95.00 From $113.50.
Citigroup Cut RTX (NYSE:RTX) Price Target to $95.00 From $113.50 Read Post »
Morgan Stanley lowers RTX (NYSE:RTX) price target from $110 to $95
Morgan Stanley analyst Kristine Liwag downgrades RTX (NYSE:RTX) from Overweight to Equal-Weight and lowers the price target from $110 to $95.
Morgan Stanley lowers RTX (NYSE:RTX) price target from $110 to $95 Read Post »
Wells Fargo raises RTX (NYSE:RTX) price target from $98 to $100
Wells Fargo analyst Matthew Akers maintains RTX (NYSE:RTX) with a Equal-Weight and raises the price target from $98 to $100.
Wells Fargo raises RTX (NYSE:RTX) price target from $98 to $100 Read Post »
Bank of America lowers RTX (NYSE:RTX) price target from $120 to $95
Bank of America Securities analyst Ronald Epstein downgrades RTX (NYSE:RTX) from Buy to Neutral and lowers the price target from $120 to $95.
Bank of America lowers RTX (NYSE:RTX) price target from $120 to $95 Read Post »
ON Semiconductor (NASDAQ:ON) Q2 Non-GAAP Earnings Drop, Revenue Flat; Sets Q3 Guidance
ON Semiconductor (NASDAQ:ON) reported Q2 non-GAAP earnings of $1.33 per diluted share, down from $1.34 a year earlier. Analysts polled by Capital IQ expected $1.21. Revenue for the quarter ended June 30 was $2.09 billion, flat compared with a year earlier. Analysts surveyed by Capital IQ expected $2.02 billion. The company said it expects Q3 non-GAAP EPS of $1.27 to $1.41 on revenue of $2.1 billion to $2.2 billion. Analysts polled by Capital IQ are looking for $1.21 and $2.06 billion, respectively.
ON Semiconductor (NASDAQ:ON) Q2 Non-GAAP Earnings Drop, Revenue Flat; Sets Q3 Guidance Read Post »
Oppenheimer raises Booking Holdings (NASDAQ:BKNG) price target from $3000 to $3500
Oppenheimer analyst Jed Kelly maintains Booking Holdings (NASDAQ:BKNG) with a Outperform and raises the price target from $3000 to $3500.
Oppenheimer raises Booking Holdings (NASDAQ:BKNG) price target from $3000 to $3500 Read Post »
Morgan Stanley announces Exelixis (NASDAQ:EXEL) $21 price target
Morgan Stanley analyst Jefferson Harralson reinstates Exelixis (NASDAQ:EXEL) with a Equal-Weight and announces $21 price target.
Morgan Stanley announces Exelixis (NASDAQ:EXEL) $21 price target Read Post »
Oppenheimer maintains Exelixis (NASDAQ:EXEL) $25 price target
Oppenheimer analyst Jay Olson reiterates Exelixis (NASDAQ:EXEL) with a Outperform and maintains $25 price target.
Oppenheimer maintains Exelixis (NASDAQ:EXEL) $25 price target Read Post »
Adobe (NASDAQ:ADBE) Price Target Raised to $660.00/Share From $510.00 by Morgan Stanley
Adobe (NASDAQ:ADBE) Price Target Raised to $660.00/Share From $510.00 by Morgan Stanley.
Adobe (NASDAQ:ADBE) Price Target Raised to $660.00/Share From $510.00 by Morgan Stanley Read Post »
Barclays lowers Procter & Gamble (NYSE:PG) price target from $167 to $160
Barclays analyst Lauren Lieberman maintains Procter & Gamble (NYSE:PG) with a Overweight and lowers the price target from $167 to $160.
Barclays lowers Procter & Gamble (NYSE:PG) price target from $167 to $160 Read Post »
Morgan Stanley maintains Procter & Gamble (NYSE:PG) $174 price target
Morgan Stanley analyst Dara Mohsenian reiterates Procter & Gamble (NYSE:PG) with a Overweight and maintains $174 price target.
Morgan Stanley maintains Procter & Gamble (NYSE:PG) $174 price target Read Post »
Procter & Gamble (NYSE:PG) Fiscal Q4 Non-GAAP Earnings, Net Sales Rise; Fiscal 2024 Guidance Issued
Procter & Gamble Co. (NYSE:PG) reported fiscal Q4 non-GAAP earnings of $1.37 per diluted share, up from $1.21 per share a year earlier. Analysts polled by Capital IQ expected adjusted EPS of $1.32. Net sales for the quarter ended June 30 were $20.55 billion, compared with $19.52 billion a year earlier. Analysts surveyed by Capital IQ expected $19.32 billion. For fiscal 2024, the company expects EPS to be between $6.25 and $6.43. Analysts polled by Capital IQ expect EPS of $6.40. All-in sales growth for the fiscal year is projected to be 3% to 4%, while organic sales growth is expected to come in between 4% and 5%.